FOLFOXIRI Plus Bevacizumab as First-line Treatment for BRAF V600E Mutant Metastatic Colorectal Cancer: a Prospective Evaluation
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 24 Sep 2011 New trial record
- 21 Sep 2011 Biomarkers information updated